Clinical Trial Update: A Study to Assess the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics (PK) of TAK-931 in Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial assessing relative bioavailability, food effect, and gastric pH modification on TAK-931 pharmacokinetics in participants with advanced solid tumor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms
• Solid Tumors

Drugs mentioned

• TAK-931 (TAK-931)

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Neoplasms, Advanced Solid | Phase 1 | Status: COMPLETED | Results posted: 2020-12-29